DBVT

#2282
DBV Technologies S.A.
21.64 USD
-2.26%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
21.64
21.64
Year Range
7.00
26.19
Daily Change
-2.26%
Monthly Change
+5.61%
6 month change
+40.25%
Year Change
+192.83%
Previous Close
22.14
Open
21.64
Bid
Ask
Low
21.64
High
21.64
Volume
25
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

News